4:44 PM
Jun 19, 2019
 |  BC Extra  |  Company News

Management tracks: Ultragenyx promotes Erik Harris; plus F-star, Arbutus, Maze and more

Editor's Note: This article was updated on Jul 03, 2019 at 12:25 PM PDT

Rare disease company Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) promoted Erik Harris to EVP and chief commercial officer from SVP, head of North American commercial operations.

Bispecific antibody company F-star Biotechnology Ltd. (Cambridge, U.K.) said CFO Tolga Hassan will become COO. Darlene Deptula-Hicks will succeed Hassan as CFO. She was CFO of Northern Biologics Inc. (Toronto, Ont.).

HBV company Arbutus Biopharma Corp. (NASDAQ:ABUS) said President and CEO Mark Murray will retire on June 23. He...

Read the full 344 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >